This report by Visiongain provides an analysis of the Global Automation in Biopharma Industry Market, which was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033. Automation in biopharma industry can help reduce the risk of contamination and improve consistency and quality in several ways, such as precision, accuracy, and reliability. The report provides an analysis of the market by technology, application, component, automation technology, digitization technology, and regional and leading national market analysis.